Search

everythinglearnresearchcommunity

for

Search:↓

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Resveratrol-loaded nanovesicles effectively promote hair growth and treat hair loss.

Dutasteride may help reduce brain inflammation and improve cognition.

5-ARI therapy may help prevent prostate cancer progression.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Platelet lysate effectively promotes hair growth and improves hair thickness in people with androgenetic alopecia.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Finasteride slows down motherly behavior in first-time pregnant rats.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

PRP is a promising treatment for hair loss.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

The document does not give specific results for hair loss treatment effectiveness.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Early detection and treatment of primary biliary cirrhosis and related autoimmune diseases improve outcomes.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Upadacitinib may cause hair loss.